Contribution: Industrial Research Assistance Program – Contributions to Firms
Pividl Bioscience Inc.
$74,795.00
Evaluation of Bio-Based Nanocarriers for Application in Drug Delivery Platforms
FY 2023-24 · 2023-06-01
Summary
The bio-based nanocarriers produced with Pividl's patent pending technology will be investigated as multidrug and bioactive novel delivery systems. Formation mechanism, stability, encapsulation efficiency and other wet lab studies will enable us to determine which nanocarrier candidate will be selected for advancement and commercialization.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Moncton|Moncton, New Brunswick, Canada
Recipient Type
For-profit organization
Business Number
730916079
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2023-06-01 | 2023-24 | $30,960.00 |
| 1 | 2023-06-01 | 2023-24 | $74,795.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The total amended value is 43,835 dollars.
Additional Information (French)
Cet accord a été modifié 1 fois La valeur totale des modifications est de 43 835 dollars.
Agreement End Date
2024-04-30
Agreement Number
1006877
Agreement Start Date
2023-06-01
Agreement Title
Evaluation of Bio-Based Nanocarriers for Application in Drug Delivery Platforms
Agreement Title (French)
Évaluation des nanovecteurs d’origine biologique en vue de leur application dans les plateformes d’administration de médicaments
Agreement Type
Contribution
Agreement Value
$74,795.00
Amendment Date
2023-07-07
Amendment Number
1
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
The bio-based nanocarriers produced with Pividl's patent pending technology will be investigated as multidrug and bioactive novel delivery systems. Formation mechanism, stability, encapsulation efficiency and other wet lab studies will enable us to determine which nanocarrier candidate will be selected for advancement and commercialization.
Description (French)
Les nanovecteurs produits à partir de la technologie brevetée de Pividl seront étudiés en tant que nouveaux systèmes de délivrance de médicaments multiples et bioactifs. Le mécanisme de formation, la stabilité, l’efficacité de l’encapsulation et d’autres études en laboratoire humide nous permettront de déterminer quel nanovecteur potentiel sera sélectionné pour l’avancement et la commercialisation.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Moncton--Riverview--Dieppe
Federal Riding (French)
Moncton--Riverview--Dieppe
Federal Riding Number
13007
NAICS Code
33149
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
730916079
Recipient City
Moncton|Moncton
Recipient Country
CA
Recipient Legal Name
Pividl Bioscience Inc.
Recipient Operating Name
Pividl Bioscience Inc.
Recipient Postal Code
E1C 4X7
Recipient Province or Territory
NB
Recipient Type
F
Reference Number
172-2023-2024-Q1-1006877
